1h Free Analyst Time
The Organ Preservation Market size was estimated at USD 503.93 million in 2023, USD 541.48 million in 2024, and is expected to grow at a CAGR of 7.72% to reach USD 848.57 million by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Organ preservation is an important step in the transplant process to maintain the organ and tissue functional state during organ transplantation. Organ preservation is based on the effects of cooling and hypothermic machine perfusion (HMP) methods to slow biological deterioration in organs removed from their normal physiological environment to match the most suitable recipient patient through organ exchange. The rising instances of organ failure, increasing organ transplantation surgeries, and rising awareness of organ donation activities create a need for organ preservation solutions worldwide. However, the high cost of organ cryopreservation activity and the increasing availability of artificial organs may limit the adoption of organ preservation solutions. Moreover, ongoing technological advancements in research and development of organ cryopreservation are revolutionizing the market. Continuous extension of clinical service offerings and encouragement for organ donation activities by government and NGOs are expected to boost the adoption of organ preservation solutions.
Regional Insights
Organ preservation is growing in the Americas as organ transplantations are increasing due to increased donor matching and improvements in immunosuppressive drugs. The advanced organ preservation methods allow more flexibility in transporting organs of all types to broader geographic locations to address the current critical organ shortage in America. In the European region, organ preservation and transplantation are managed in conformity with the Council of Europe's binding laws and compliant with relevant EU rules. The rising consent for organ donation activities across European countries is increasing market demand for organ preservation solutions. The ongoing research and development of innovative technologies in organ transplants are expected to create lucrative opportunities in organ preservation solutions in the Asia-Pacific region. The relatively low cost of organ transplantation surgeries in countries such as India and China has boosted the region's demand for organ preservation solutions.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Organ Preservation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Organ Preservation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Organ Preservation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, Artivion, Inc., AVIONORD S.R.L., BioLife Solutions Inc., Bridge to Life Ltd., CARDIOLINK S.L., Carnamedica, Dr. Franz Köhler Chemie GmbH, EBERS MEDICAL TECHNOLOGY SL, Essential Pharmaceuticals, LLC by Accord Healthcare Limited, Global Transplant Solutions, Inc., Hemarina SA, Institut Georges Lopez, Lifeline Scientific, Inc., Organ Preservation Solutions Ltd., OrganOx Limited, Paragonix Technologies, Inc., Preservation Solutions, Inc., S.A.L.F. S.p.A., Sandor Medicaids Pvt. Ltd., SAS Advanced Life Solutions, ScubaTx Limited, TransMedics, Inc., TX Innovations B.V., Vascular Perfusion Solutions, Inc., and XVIVO AB.Market Segmentation & Coverage
This research report categorizes the Organ Preservation Market to forecast the revenues and analyze trends in each of the following sub-markets:- Preservation Solution
- Celsior Solution
- Custodial HTK
- IGL-1 Solution
- Perfadex
- University of Wisconsin (UW)
- Organ Type
- Heart
- Kidneys
- Liver
- Lung
- Technique
- Controlled Oxygenated Rewarming
- Ex vivo Machine Perfusion
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Static Cold Storage
- End-User
- Hospitals
- Organ Transplant Centers
- Specialty Clinics
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Organ Preservation Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Organ Preservation Market?
- What are the technology trends and regulatory frameworks in the Organ Preservation Market?
- What is the market share of the leading vendors in the Organ Preservation Market?
- Which modes and strategic moves are suitable for entering the Organ Preservation Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Organ Preservation Market, by Preservation Solution
7. Organ Preservation Market, by Organ Type
8. Organ Preservation Market, by Technique
9. Organ Preservation Market, by End-User
10. Americas Organ Preservation Market
11. Asia-Pacific Organ Preservation Market
12. Europe, Middle East & Africa Organ Preservation Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
List of Figures
List of Tables
Companies Mentioned
- 21st Century Medicine
- Artivion, Inc.
- AVIONORD S.R.L.
- BioLife Solutions Inc.
- Bridge to Life Ltd.
- CARDIOLINK S.L.
- Carnamedica
- Dr. Franz Köhler Chemie GmbH
- EBERS MEDICAL TECHNOLOGY SL
- Essential Pharmaceuticals, LLC by Accord Healthcare Limited
- Global Transplant Solutions, Inc.
- Hemarina SA
- Institut Georges Lopez
- Lifeline Scientific, Inc.
- Organ Preservation Solutions Ltd.
- OrganOx Limited
- Paragonix Technologies, Inc.
- Preservation Solutions, Inc.
- S.A.L.F. S.p.A.
- Sandor Medicaids Pvt. Ltd.
- SAS Advanced Life Solutions
- ScubaTx Limited
- TransMedics, Inc.
- TX Innovations B.V.
- Vascular Perfusion Solutions, Inc.
- XVIVO AB
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 198 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 541.48 Million |
| Forecasted Market Value ( USD | $ 848.57 Million |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
